Significance of ipsilateral breast tumour recurrence after lumpectomy

The Lancet

Volumn 338, Issue 8763, 1991, Pages 327-331

  Fisher, B ^a   Anderson, S ^a   Fisher, E R ^a   Redmond, C ^a   Wickerham, D L ^a   Wolmark, N ^a   Mamounas, E P ^a   Deutsch, M ^a   Margolese, R ^a  

^a NSABP Foundation Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TUMOR RECURRENCE;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMAN; LIFE TABLES; MASTECTOMY, SEGMENTAL; MASTECTOMY, SIMPLE; MIDDLE AGE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE;

EID: 0025914840     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(91)90475-5     Document Type: Article

References (18)

1. Comparison of radical mastectomy with alternative treatments for primary breast cancer: a first report of results from a prospective randomized clinical trial
2. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation
3. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer
4. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without radiation in the treatment of breast cancer
5. Lumpectomy and axillary dissection for breast cancer: surgical, pathologic and radiation considerations
6. Maximum utilization of the life table method in analyzing survival
7. Regression models and life tables
8. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no 4): discriminants for five-year treatment failure
9. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no 4) X: discriminants for tenth-year treatment failure
10. Histologic grading of breast cancer
11. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP): prognostic discriminants for 8-year survival in 950 patients with node-negative invasive breast cancer
12. Evaluating serial cancer market studies in patients at risk of recurrent disease
13. Asymptotically efficient rank invariant test procedures
14. Survival following locoregional recurrence after breast conservation therapy for cancer
15. Laboratory and clinical research in breast cancer: a personal adventure: the David A. Karnofsky memorial lecture